Finerenone History and Updates

242 events · 2004 – present

Synced daily from openFDA and ClinicalTrials.gov. Last sync: June 12, 2026.

FDA Approvals

Label Revisions

242

Trial Milestones

Pivotal Publications

Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-06-08Download chart as PNG

This page tracks every FDA action, clinical trial milestone, and major publication for Finerenone since 2004, drawn from openFDA, ClinicalTrials.gov, and PubMed.

All published updates (11)

2026

Pivotal publicationFinerenone Study Results Published for Type 1 Diabetes and CKD· Jan 1, 2026

2025

Primary completionFinerenone Completes Phase 3 Trial for Non-diabetic Chronic Kidney Disease· Dec 31, 2025
Primary completionFinerenone Phase 3 Trial for Type 2 Diabetes Completes Primary Study· Nov 25, 2025
Results postedFinerenone Reduces CV Death, HF Events in Heart Failure with LVEF ≥40%· Aug 26, 2025
Primary completionFinerenone Phase 3 Trial for CKD and Type 1 Diabetes Completes· Aug 20, 2025
FDA approval (supplemental)Kerendia (Finerenone) Receives FDA Supplemental Efficacy Approval· Jul 11, 2025

2024

Pivotal publicationFinerenone Meta-Analysis on MRAs in Heart Failure Published in Lancet· Jan 1, 2024
Pivotal publicationFinerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction…· Jan 1, 2024

2021

Pivotal publicationFinerenone: Cardiovascular Events in Kidney Disease and Type 2 Diabetes· Jan 1, 2021

2020

Pivotal publicationEffect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes· Jan 1, 2020

2004

Pivotal publicationFinerenone: Pivotal Publication on LV Mass Change in Hypertension· Jan 1, 2004

Upcoming & expected milestones

Primary completionJun 30, 2026· ClinicalTrials.gov

Primary completion: NCT06763146

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Typ

Primary completionJun 30, 2026· ClinicalTrials.gov

NA primary completion: NCT07326631

Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

Trial startedJul 1, 2026· ClinicalTrials.gov

Phase 3 trial started: NCT07575672

Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure

Primary completionJul 31, 2026· ClinicalTrials.gov

Phase 3 primary completion: NCT07223502

A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone

Primary completionJul 31, 2026· ClinicalTrials.gov

Phase 3 primary completion: NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATI

Primary completionJul 31, 2026· ClinicalTrials.gov

Phase 4 primary completion: NCT06727409

Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i

Trial startedSep 1, 2026· ClinicalTrials.gov

Phase 2 trial started: NCT07594145

Precision T1D Platform - New Therapies for Cardio-Renal Complications

Primary completionSep 30, 2026· ClinicalTrials.gov

Primary completion: NCT06278207

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works

Primary completionSep 30, 2026· ClinicalTrials.gov

Primary completion: NCT05348733

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Primary completionOct 26, 2026· ClinicalTrials.gov

Primary completion: NCT05348733

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Primary completionOct 30, 2026· ClinicalTrials.gov

Phase 4 primary completion: NCT06573411

Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy

Primary completionOct 31, 2026· ClinicalTrials.gov

Phase 4 primary completion: NCT07523867

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

Primary completionNov 30, 2026· ClinicalTrials.gov

Phase 4 primary completion: NCT06954090

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Primary completionDec 20, 2026· ClinicalTrials.gov

Phase 4 primary completion: NCT07235891

Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease

Primary completionDec 31, 2026· ClinicalTrials.gov

Primary completion: NCT07379840

A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea

Primary completionDec 31, 2026· ClinicalTrials.gov

Phase 4 primary completion: NCT07026539

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Primary completionMar 31, 2027· ClinicalTrials.gov

Phase 2 primary completion: NCT06059664

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Primary completionApr 30, 2027· ClinicalTrials.gov

Phase 4 primary completion: NCT07537088

Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic

Primary completionJul 31, 2027· ClinicalTrials.gov

Phase 3 primary completion: NCT05196035

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body,

Primary completionJul 31, 2027· ClinicalTrials.gov

Phase 4 primary completion: NCT07155694

Role of Finerenone in African American Veterans With Diabetic Kidney Disease

Primary completionSep 1, 2027· ClinicalTrials.gov

Primary completion: NCT05348733

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Primary completionSep 30, 2027· ClinicalTrials.gov

Primary completion: NCT07232537

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and T

Primary completionOct 31, 2027· ClinicalTrials.gov

Phase 4 primary completion: NCT07315191

Finerenone Therapy for Pediatric HSPN With Mild Proteinuria

Primary completionNov 30, 2027· ClinicalTrials.gov

Phase 3 primary completion: NCT06008197

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Primary completionDec 31, 2027· ClinicalTrials.gov

Phase 3 primary completion: NCT07181135

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

Primary completionDec 31, 2027· ClinicalTrials.gov

Phase 4 primary completion: NCT07397650

Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure

Primary completionJan 31, 2028· ClinicalTrials.gov

Phase 2 primary completion: NCT06906081

Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study

Primary completionMar 31, 2028· ClinicalTrials.gov

Phase 3 primary completion: NCT06033950

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme

Primary completionMar 31, 2028· ClinicalTrials.gov

NA primary completion: NCT07585526

Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With A

Primary completionJun 30, 2028· ClinicalTrials.gov

Phase 4 primary completion: NCT07239570

A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease

Primary completionAug 30, 2028· ClinicalTrials.gov

Phase 3 primary completion: NCT06058585

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

Primary completionDec 31, 2028· ClinicalTrials.gov

Phase 4 primary completion: NCT07442448

Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure

Primary completionJan 28, 2029· ClinicalTrials.gov

Phase 3 primary completion: NCT05457283

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Rece

Primary completionMar 31, 2029· ClinicalTrials.gov

Phase 4 primary completion: NCT07547878

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Primary completionApr 30, 2029· ClinicalTrials.gov

Primary completion: NCT07554469

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CK

Primary completionJul 1, 2029· ClinicalTrials.gov

Phase 3 primary completion: NCT06082063

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Primary completionNov 30, 2029· ClinicalTrials.gov

Phase 3 primary completion: NCT07188805

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Place

Primary completionDec 31, 2029· ClinicalTrials.gov

Phase 3 primary completion: NCT07575672

Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure

Primary completionDec 31, 2029· ClinicalTrials.gov

Phase 2 primary completion: NCT07594145

Precision T1D Platform - New Therapies for Cardio-Renal Complications

Primary completionDec 30, 2030· ClinicalTrials.gov

Phase 3 primary completion: NCT07192952

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults

Primary completionDec 31, 2030· ClinicalTrials.gov

Phase 3 primary completion: NCT07270367

Finerenone and Cardiac Remodeling

Primary completionMar 1, 2036· ClinicalTrials.gov

Primary completion: NCT02378805

Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

Past events

2026

Primary completionJun 8, 2026· ClinicalTrials.gov

Phase 3 primary completion: NCT06580288

Effect of Finerenone in IgA Nephropathy

Trial startedJun 1, 2026· ClinicalTrials.gov

Phase 3 trial started: NCT07192952

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults

Trial startedMay 31, 2026· ClinicalTrials.gov

Trial started: NCT07554469

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CK

Trial startedMay 31, 2026· ClinicalTrials.gov

Phase 4 trial started: NCT07537088

Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic

Primary completionMay 21, 2026· ClinicalTrials.gov

NA primary completion: NCT07056595

Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

Trial registeredMay 18, 2026· ClinicalTrials.gov

Phase 2 trial registered on ClinicalTrials.gov: NCT07594145

Precision T1D Platform

Trial registeredMay 13, 2026· ClinicalTrials.gov

NA trial registered on ClinicalTrials.gov: NCT07585526

Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With A

Trial registeredMay 8, 2026· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT07575672

Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure

Primary completionApr 30, 2026· ClinicalTrials.gov

Phase 4 primary completion: NCT07351864

Finerenone Plus SGLT2 Inhibitors in Heart Failure

Trial startedApr 30, 2026· ClinicalTrials.gov

Phase 4 trial started: NCT07442448

Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure

Trial startedApr 30, 2026· ClinicalTrials.gov

Phase 4 trial started: NCT07523867

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

Trial startedApr 30, 2026· ClinicalTrials.gov

Trial started: NCT07554469

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CK

Trial registeredApr 28, 2026· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT07554469

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CK

Trial registeredApr 23, 2026· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07547878

Simultaneous Starting of the 4 Guideline Directed CKD Therapies (RAPID-CKD)

Trial registeredApr 17, 2026· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07537088

Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic

Trial registeredApr 13, 2026· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07523867

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

Trial startedApr 9, 2026· ClinicalTrials.gov

Phase 4 trial started: NCT07547878

Simultaneous Starting of the 4 Guideline Directed CKD Therapies (RAPID-CKD)

Trial startedMar 13, 2026· ClinicalTrials.gov

Phase 3 trial started: NCT07181135

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

Trial registeredMar 2, 2026· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07442448

Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure

Primary completionMar 1, 2026· ClinicalTrials.gov

Phase 2 primary completion: NCT06835322

Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis

Trial startedFeb 28, 2026· ClinicalTrials.gov

Phase 4 trial started: NCT07397650

Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure

Primary completionFeb 28, 2026· ClinicalTrials.gov

Primary completion: NCT07124039

An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How

Trial registeredFeb 9, 2026· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07397650

Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure

Trial registeredFeb 2, 2026· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT07379840

A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea

Trial registeredJan 20, 2026· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07351864

Finerenone Plus SGLT2 Inhibitors in Heart Failure

Trial startedJan 18, 2026· ClinicalTrials.gov

Phase 4 trial started: NCT07351864

Finerenone Plus SGLT2 Inhibitors in Heart Failure

Trial registeredJan 8, 2026· ClinicalTrials.gov

NA trial registered on ClinicalTrials.gov: NCT07326631

Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

Trial registeredJan 2, 2026· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07315191

Finerenone Therapy for Pediatric HSPN With Mild Proteinuria

Pivotal publicationJan 1, 2026· PubMed

Finerenone in Type 1 Diabetes and Chronic Kidney Disease. (N Engl J Med)

FINE-ONE — A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type

Trial startedJan 1, 2026· ClinicalTrials.gov

NA trial started: NCT07326631

Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

2025

Trial startedDec 31, 2025· ClinicalTrials.gov

Phase 3 trial started: NCT07270367

Finerenone and Cardiac Remodeling

Primary completionDec 31, 2025· ClinicalTrials.gov

Primary completion: NCT06838416

Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease

Primary completionDec 31, 2025· ClinicalTrials.gov

Phase 3 primary completion: NCT05047263

A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

Trial startedDec 23, 2025· ClinicalTrials.gov

Trial started: NCT07379840

A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea

Trial registeredDec 8, 2025· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT07270367

Finerenone and Cardiac Remodeling

Trial startedDec 1, 2025· ClinicalTrials.gov

Phase 3 trial started: NCT07223502

A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone

Primary completionNov 25, 2025· ClinicalTrials.gov

Phase 3 primary completion: NCT06244758

Finerenone and Renal Oxidative Stress

Trial startedNov 20, 2025· ClinicalTrials.gov

Phase 4 trial started: NCT07235891

Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease

Trial registeredNov 20, 2025· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07239570

A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease

Trial startedNov 20, 2025· ClinicalTrials.gov

Phase 4 trial started: NCT06954090

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Trial startedNov 20, 2025· ClinicalTrials.gov

Trial started: NCT07232537

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and T

Trial startedNov 19, 2025· ClinicalTrials.gov

Phase 3 trial started: NCT07188805

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Place

Trial registeredNov 19, 2025· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07235891

Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease

Primary completionNov 18, 2025· ClinicalTrials.gov

Primary completion: NCT05552339

A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mel

Trial registeredNov 18, 2025· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT07232537

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and T

Trial registeredOct 31, 2025· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT07223502

A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone

Primary completionOct 1, 2025· ClinicalTrials.gov

Phase 2 primary completion: NCT06818305

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patien

Trial startedSep 30, 2025· ClinicalTrials.gov

Phase 4 trial started: NCT07155694

Role of Finerenone in African American Veterans With Diabetic Kidney Disease

Trial registeredSep 25, 2025· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT07192952

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults

Primary completionSep 24, 2025· ClinicalTrials.gov

Phase 4 primary completion: NCT06094920

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Trial registeredSep 23, 2025· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT07188805

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Place

Trial startedSep 22, 2025· ClinicalTrials.gov

Trial started: NCT06763146

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Typ

Trial registeredSep 18, 2025· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT07181135

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

Trial registeredSep 4, 2025· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07155694

Role of Finerenone in African American Veterans With Diabetic Kidney Disease

Results postedAug 26, 2025· ClinicalTrials.gov

Trial results posted: NCT04435626

Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection

Primary completionAug 20, 2025· ClinicalTrials.gov

Phase 2 primary completion: NCT06835322

Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis

Primary completionAug 20, 2025· ClinicalTrials.gov

Phase 3 primary completion: NCT05901831

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability

Trial registeredAug 15, 2025· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT07124039

An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How

Trial registeredAug 11, 2025· ClinicalTrials.gov

Phase 1 trial registered on ClinicalTrials.gov: NCT07116512

A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of

Trial startedJul 16, 2025· ClinicalTrials.gov

Trial started: NCT07124039

An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How

FDA approval (supplemental)Jul 11, 2025· FDA

FDA approved supplemental application for Kerendia (finerenone) — Efficacy (NDA 215341 S-9)

Sponsor: BAYER HLTHCARE. Class: Efficacy.

Trial registeredJul 9, 2025· ClinicalTrials.gov

NA trial registered on ClinicalTrials.gov: NCT07056595

Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

Primary completionJul 3, 2025· ClinicalTrials.gov

Phase 4 primary completion: NCT05705271

A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Abilit

Trial startedJun 20, 2025· ClinicalTrials.gov

Phase 4 trial started: NCT07239570

A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease

Trial registeredJun 18, 2025· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT07026539

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Trial startedJun 13, 2025· ClinicalTrials.gov

Phase 4 trial started: NCT07315191

Finerenone Therapy for Pediatric HSPN With Mild Proteinuria

Primary completionJun 1, 2025· ClinicalTrials.gov

Phase 4 primary completion: NCT06457074

Finerenone for Patients With Primary Aldosteronism (FAIRY)

Primary completionJun 1, 2025· ClinicalTrials.gov

Phase 4 primary completion: NCT06381323

The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Trial startedMay 21, 2025· ClinicalTrials.gov

NA trial started: NCT07056595

Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

Trial startedMay 2, 2025· ClinicalTrials.gov

Phase 2 trial started: NCT06906081

Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study

Trial registeredMay 1, 2025· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT06954090

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Trial registeredApr 2, 2025· ClinicalTrials.gov

Phase 2 trial registered on ClinicalTrials.gov: NCT06906081

Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study

Primary completionMar 31, 2025· ClinicalTrials.gov

Phase 4 primary completion: NCT05814770

Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Primary completionMar 31, 2025· ClinicalTrials.gov

Primary completion: NCT06608212

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Dia

Primary completionMar 14, 2025· ClinicalTrials.gov

Phase 2 primary completion: NCT05254002

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alon

Primary completionFeb 28, 2025· ClinicalTrials.gov

Phase 4 primary completion: NCT05887817

Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)

Trial startedFeb 20, 2025· ClinicalTrials.gov

Phase 2 trial started: NCT06835322

Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis

Trial registeredFeb 20, 2025· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT06838416

Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease

Trial registeredFeb 19, 2025· ClinicalTrials.gov

Phase 2 trial registered on ClinicalTrials.gov: NCT06835322

Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis

Trial registeredFeb 10, 2025· ClinicalTrials.gov

Phase 2 trial registered on ClinicalTrials.gov: NCT06818305

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patien

Trial registeredJan 8, 2025· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT06763146

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Typ

Trial startedJan 1, 2025· ClinicalTrials.gov

Phase 2 trial started: NCT06818305

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patien

2024

Primary completionDec 16, 2024· ClinicalTrials.gov

Phase 4 primary completion: NCT06164379

Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism

Trial startedDec 12, 2024· ClinicalTrials.gov

Phase 4 trial started: NCT06727409

Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i

Trial registeredDec 10, 2024· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT06727409

Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i

Trial startedOct 23, 2024· ClinicalTrials.gov

Phase 4 trial started: NCT07026539

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Trial startedOct 9, 2024· ClinicalTrials.gov

Trial started: NCT06608212

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Dia

Trial startedOct 8, 2024· ClinicalTrials.gov

Phase 3 trial started: NCT06580288

Effect of Finerenone in IgA Nephropathy

Primary completionOct 1, 2024· ClinicalTrials.gov

Primary completion: NCT05703880

An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well

Trial startedSep 30, 2024· ClinicalTrials.gov

Phase 4 trial started: NCT06573411

Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy

Primary completionSep 23, 2024· ClinicalTrials.gov

Phase 2 primary completion: NCT05897372

Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study

Trial registeredSep 23, 2024· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT06608212

An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Dia

Primary completionSep 5, 2024· ClinicalTrials.gov

Primary completion: NCT05526157

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How

Trial startedSep 4, 2024· ClinicalTrials.gov

Phase 3 trial started: NCT06058585

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

Trial registeredAug 30, 2024· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT06580288

Effect of Finerenone in IgA Nephropathy

Trial registeredAug 27, 2024· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT06573411

Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy

Trial startedAug 20, 2024· ClinicalTrials.gov

Phase 3 trial started: NCT06033950

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme

Trial startedJul 29, 2024· ClinicalTrials.gov

Phase 4 trial started: NCT06094920

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Trial startedJul 9, 2024· ClinicalTrials.gov

Phase 3 trial started: NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATI

Trial startedJul 1, 2024· ClinicalTrials.gov

Phase 3 trial started: NCT06082063

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Trial registeredJun 14, 2024· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT06460987

Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

Trial registeredJun 13, 2024· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT06457074

Finerenone for Patients With Primary Aldosteronism (FAIRY)

Trial startedJun 4, 2024· ClinicalTrials.gov

Phase 4 trial started: NCT06457074

Finerenone for Patients With Primary Aldosteronism (FAIRY)

Trial startedMay 15, 2024· ClinicalTrials.gov

Trial started: NCT06278207

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works

Primary completionMay 15, 2024· ClinicalTrials.gov

Phase 3 primary completion: NCT04435626

Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection

Trial registeredApr 24, 2024· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT06381323

The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Trial startedApr 23, 2024· ClinicalTrials.gov

Phase 2 trial started: NCT06059664

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Primary completionMar 31, 2024· ClinicalTrials.gov

Primary completion: NCT06460987

Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

Primary completionMar 12, 2024· ClinicalTrials.gov

Phase 4 primary completion: NCT05924620

Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism

Trial startedMar 1, 2024· ClinicalTrials.gov

Phase 4 trial started: NCT06381323

The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Trial registeredFeb 26, 2024· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT06278207

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works

Trial startedFeb 26, 2024· ClinicalTrials.gov

Phase 3 trial started: NCT05901831

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability

Trial registeredFeb 6, 2024· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT06244758

Finerenone and Renal Oxidative Stress

Trial startedJan 18, 2024· ClinicalTrials.gov

Phase 3 trial started: NCT06244758

Finerenone and Renal Oxidative Stress

Trial startedJan 17, 2024· ClinicalTrials.gov

Phase 3 trial started: NCT06008197

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Pivotal publicationJan 1, 2024· PubMed

Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis. (Lancet)

FINEARTS-HF — Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Gr

Pivotal publicationJan 1, 2024· PubMed

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. (N Engl J Med)

2023

Primary completionDec 20, 2023· ClinicalTrials.gov

Primary completion: NCT05640180

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-

Trial startedDec 16, 2023· ClinicalTrials.gov

Phase 4 trial started: NCT06164379

Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism

Trial registeredDec 11, 2023· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT06164379

Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism

Trial startedNov 17, 2023· ClinicalTrials.gov

Trial started: NCT06838416

Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease

Trial registeredOct 23, 2023· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT06094920

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Trial registeredOct 13, 2023· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT06082063

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Trial registeredSep 29, 2023· ClinicalTrials.gov

Phase 2 trial registered on ClinicalTrials.gov: NCT06059664

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Trial registeredSep 28, 2023· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT06058585

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

Trial registeredSep 13, 2023· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT06033950

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme

Trial startedSep 7, 2023· ClinicalTrials.gov

Phase 4 trial started: NCT05887817

Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)

Trial registeredSep 6, 2023· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATI

Trial registeredAug 23, 2023· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT06008197

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Trial startedAug 18, 2023· ClinicalTrials.gov

Trial started: NCT05552339

A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mel

Trial startedAug 1, 2023· ClinicalTrials.gov

Phase 2 trial started: NCT05897372

Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study

Primary completionJul 28, 2023· ClinicalTrials.gov

Phase 1 primary completion: NCT07116512

A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of

Trial registeredJun 29, 2023· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT05924620

Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism

Trial startedJun 21, 2023· ClinicalTrials.gov

Phase 4 trial started: NCT05924620

Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism

Trial registeredJun 13, 2023· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT05901831

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability

Trial registeredJun 9, 2023· ClinicalTrials.gov

Phase 2 trial registered on ClinicalTrials.gov: NCT05897372

Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study

Trial registeredJun 5, 2023· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT05887817

Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)

Trial startedJun 1, 2023· ClinicalTrials.gov

Trial started: NCT05703880

An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well

Trial startedMay 31, 2023· ClinicalTrials.gov

Phase 4 trial started: NCT05814770

Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Trial startedMay 2, 2023· ClinicalTrials.gov

Phase 1 trial started: NCT07116512

A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of

Trial registeredApr 18, 2023· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT05814770

Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Results postedMar 31, 2023· ClinicalTrials.gov

Trial results posted: NCT05013008

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicat

Trial startedFeb 8, 2023· ClinicalTrials.gov

Phase 4 trial started: NCT05705271

A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Abilit

Trial registeredJan 30, 2023· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT05703880

An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well

Trial registeredJan 30, 2023· ClinicalTrials.gov

Phase 4 trial registered on ClinicalTrials.gov: NCT05705271

A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Abilit

2022

Trial registeredDec 7, 2022· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT05640180

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-

Trial startedDec 1, 2022· ClinicalTrials.gov

Trial started: NCT06460987

Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

Trial startedNov 23, 2022· ClinicalTrials.gov

Trial started: NCT05640180

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-

Trial startedNov 8, 2022· ClinicalTrials.gov

Phase 3 trial started: NCT05457283

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Rece

Trial startedOct 1, 2022· ClinicalTrials.gov

Trial started: NCT05526157

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How

Trial registeredSep 23, 2022· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT05552339

A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mel

Trial registeredSep 2, 2022· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT05526157

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How

FDA approval (supplemental)Sep 1, 2022· FDA

FDA approved supplemental application for Kerendia (finerenone) — Efficacy (NDA 215341 S-1)

Sponsor: BAYER HLTHCARE. Class: Efficacy.

Trial registeredJul 13, 2022· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT05457283

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Rece

Trial startedJun 23, 2022· ClinicalTrials.gov

Phase 2 trial started: NCT05254002

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alon

Trial startedJun 13, 2022· ClinicalTrials.gov

Trial started: NCT05348733

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Trial registeredApr 27, 2022· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT05348733

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Results postedApr 15, 2022· ClinicalTrials.gov

Trial results posted: NCT02545049

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Trial startedMar 28, 2022· ClinicalTrials.gov

Phase 3 trial started: NCT05196035

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body,

Trial registeredFeb 24, 2022· ClinicalTrials.gov

Phase 2 trial registered on ClinicalTrials.gov: NCT05254002

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alon

Trial registeredJan 19, 2022· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT05196035

A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body,

2021

Primary completionDec 31, 2021· ClinicalTrials.gov

Phase 2 primary completion: NCT05013008

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicat

Trial startedSep 21, 2021· ClinicalTrials.gov

Phase 3 trial started: NCT05047263

A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

Trial registeredSep 17, 2021· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT05047263

A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

Trial registeredAug 19, 2021· ClinicalTrials.gov

Phase 2 trial registered on ClinicalTrials.gov: NCT05013008

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicat

Trial startedAug 18, 2021· ClinicalTrials.gov

Phase 2 trial started: NCT05013008

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicat

Results postedJul 19, 2021· ClinicalTrials.gov

Trial results posted: NCT02540993

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

FDA approvalJul 9, 2021· FDA

FDA approved Kerendia (finerenone) (NDA 215341)

Sponsor: BAYER HLTHCARE. Class: Type 1 - New Molecular Entity.

Primary completionJun 30, 2021· ClinicalTrials.gov

NA primary completion: NCT04795726

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Fine

Primary completionJun 25, 2021· ClinicalTrials.gov

Primary completion: NCT04477707

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Fine

Results postedJun 15, 2021· ClinicalTrials.gov

Trial results posted: NCT01807221

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricu

Trial registeredJun 1, 2021· ClinicalTrials.gov

Phase 1 trial registered on ClinicalTrials.gov: NCT04908436

A Study to Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants Wi

Trial registeredMay 11, 2021· ClinicalTrials.gov

Phase 1 trial registered on ClinicalTrials.gov: NCT04881994

A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult P

Results postedMay 4, 2021· ClinicalTrials.gov

Trial results posted: NCT01874431

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic N

Trial registeredMar 12, 2021· ClinicalTrials.gov

NA trial registered on ClinicalTrials.gov: NCT04795726

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Fine

Trial startedMar 10, 2021· ClinicalTrials.gov

NA trial started: NCT04795726

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Fine

Primary completionFeb 2, 2021· ClinicalTrials.gov

Phase 3 primary completion: NCT02545049

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Pivotal publicationJan 1, 2021· PubMed

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. (N Engl J Med)

FIGARO-DKD — Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

2020

Trial startedSep 14, 2020· ClinicalTrials.gov

Phase 3 trial started: NCT04435626

Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection

Trial startedJul 23, 2020· ClinicalTrials.gov

Trial started: NCT04477707

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Fine

Trial registeredJul 20, 2020· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT04477707

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Fine

Trial registeredJun 17, 2020· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT04435626

Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection

Primary completionApr 14, 2020· ClinicalTrials.gov

Phase 3 primary completion: NCT02540993

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Pivotal publicationJan 1, 2020· PubMed

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. (N Engl J Med)

FIDELIO-DKD — Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

2017

Primary completionJan 13, 2017· ClinicalTrials.gov

Phase 1 primary completion: NCT02957396

Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects

2016

Primary completionDec 22, 2016· ClinicalTrials.gov

Phase 1 primary completion: NCT02956109

Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Volunteers

Trial startedNov 17, 2016· ClinicalTrials.gov

Phase 1 trial started: NCT02957396

Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects

Trial startedNov 16, 2016· ClinicalTrials.gov

Phase 1 trial started: NCT02956109

Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Volunteers

Trial registeredNov 7, 2016· ClinicalTrials.gov

Phase 1 trial registered on ClinicalTrials.gov: NCT02957396

Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects

Trial registeredNov 4, 2016· ClinicalTrials.gov

Phase 1 trial registered on ClinicalTrials.gov: NCT02956109

Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Volunteers

2015

Trial startedSep 17, 2015· ClinicalTrials.gov

Phase 3 trial started: NCT02540993

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Trial startedSep 17, 2015· ClinicalTrials.gov

Phase 3 trial started: NCT02545049

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Trial registeredSep 9, 2015· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT02545049

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Trial registeredSep 4, 2015· ClinicalTrials.gov

Phase 3 trial registered on ClinicalTrials.gov: NCT02540993

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Trial registeredMar 4, 2015· ClinicalTrials.gov

Trial registered on ClinicalTrials.gov: NCT02378805

Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

2014

Primary completionNov 11, 2014· ClinicalTrials.gov

Phase 2 primary completion: NCT01807221

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricu

Primary completionSep 16, 2014· ClinicalTrials.gov

Phase 1 primary completion: NCT04881994

A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult P

Primary completionJul 9, 2014· ClinicalTrials.gov

Phase 2 primary completion: NCT01874431

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic N

Trial startedMar 25, 2014· ClinicalTrials.gov

Phase 1 trial started: NCT04881994

A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult P

2013

Trial startedJun 17, 2013· ClinicalTrials.gov

Phase 2 trial started: NCT01807221

Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricu

Sources

FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.